Zucker BG - Search Results

1

Does nocturnal panic represent a more severe form of panic disorder?

Craske MG, Lang AJ, Mystkowski JL, Zucker BG, Bystritsky A, Yan-Go F. Craske MG, et al. Among authors: zucker bg. J Nerv Ment Dis. 2002 Sep;190(9):611-8. doi: 10.1097/00005053-200209000-00006. J Nerv Ment Dis. 2002. PMID: 12357095

2

Impact of cognitive-behavioral therapy for panic disorder on comorbidity: a controlled investigation.

Tsao JC, Mystkowski JL, Zucker BG, Craske MG. Tsao JC, et al. Among authors: zucker bg. Behav Res Ther. 2005 Jul;43(7):959-70. doi: 10.1016/j.brat.2004.11.013. Behav Res Ther. 2005. PMID: 15896289 Clinical Trial.

3

The relationship of thought-action fusion to pathologicial worry and generalized anxiety disorder.

Hazlett-Stevens H, Zucker BG, Craske MG. Hazlett-Stevens H, et al. Among authors: zucker bg. Behav Res Ther. 2002 Oct;40(10):1199-204. doi: 10.1016/s0005-7967(01)00138-3. Behav Res Ther. 2002. PMID: 12375728

4

Thought action fusion: can it be corrected?

Zucker BG, Craske MG, Barrios V, Holguin M. Zucker BG, et al. Behav Res Ther. 2002 Jun;40(6):653-64. doi: 10.1016/s0005-7967(01)00054-7. Behav Res Ther. 2002. PMID: 12051484 Clinical Trial.

5

A cognitive behavioral workshop for subclinical obsessions and compulsions.

Zucker BG, Craske MG, Blackmore MA, Nitz A. Zucker BG, et al. Behav Res Ther. 2006 Feb;44(2):289-304. doi: 10.1016/j.brat.2005.03.015. Epub 2005 Dec 22. Behav Res Ther. 2006. PMID: 16376296 Clinical Trial.

6

The anxiety sensitivity index: item analysis and suggestions for refinement.

Blais MA, Otto MW, Zucker BG, McNally RJ, Schmidt NB, Fava M, Pollack MH. Blais MA, et al. Among authors: zucker bg. J Pers Assess. 2001 Oct;77(2):272-94. doi: 10.1207/S15327752JPA7702_10. J Pers Assess. 2001. PMID: 11693859

7

Group cognitive-behavior therapy for patients failing to respond to pharmacotherapy for panic disorder: a clinical case series.

Otto MW, Pollack MH, Penava SJ, Zucker BG. Otto MW, et al. Among authors: zucker bg. Behav Res Ther. 1999 Aug;37(8):763-70. doi: 10.1016/s0005-7967(98)00176-4. Behav Res Ther. 1999. PMID: 10452176

8

Nefazodone for social phobia: a clinical case series.

Worthington JJ 3rd, Zucker BG, Fones CS, Otto MW, Pollack MH. Worthington JJ 3rd, et al. Among authors: zucker bg. Depress Anxiety. 1998;8(3):131-3. Depress Anxiety. 1998. PMID: 9836065 Clinical Trial.

9

Prevalence of body dysmorphic disorder in patients with anxiety disorders.

Wilhelm S, Otto MW, Zucker BG, Pollack MH. Wilhelm S, et al. Among authors: zucker bg. J Anxiety Disord. 1997 Sep-Oct;11(5):499-502. doi: 10.1016/s0887-6185(97)00026-1. J Anxiety Disord. 1997. PMID: 9407269

10

Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.

Pollack MH, Worthington JJ, Manfro GG, Otto MW, Zucker BG. Pollack MH, et al. Among authors: zucker bg. J Clin Psychiatry. 1997;58 Suppl 11:19-23. J Clin Psychiatry. 1997. PMID: 9363044 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters